Biblio print

Tree Display

AceDB Schema

XML Display


Author Report for: Scheiner M

No contact information in database for Scheiner M

    Title: Photoswitchable Pseudoirreversible Butyrylcholinesterase Inhibitors Allow Optical Control of Inhibition in Vitro and Enable Restoration of Cognition in an Alzheimer's Disease Mouse Model upon Irradiation
    Scheiner M, Sink A, Hoffmann M, Vrigneau C, Endres E, Carles A, Sotriffer C, Maurice T, Decker M
    Ref: Journal of the American Chemical Society, :, 2022 : PubMed


    Title: Azobioisosteres of Curcumin with Pronounced Activity against Amyloid Aggregation, Intracellular Oxidative Stress, and Neuroinflammation
    Hofmann J, Ginex T, Espargaro A, Scheiner M, Gunesch S, Arago M, Stigloher C, Sabate R, Luque FJ, Decker M
    Ref: Chemistry, 27:6015, 2021 : PubMed


    Title: From virtual screening hits targeting a cryptic pocket in BACE-1 to a nontoxic brain permeable multitarget anti-Alzheimer lead with disease-modifying and cognition-enhancing effects
    Pont C, Ginex T, Grinan-Ferre C, Scheiner M, Mattellone A, Martinez N, Arce EM, Soriano-Fernandez Y, Naldi M and Munoz-Torrero D <13 more author(s)>
    Ref: Eur Journal of Medicinal Chemistry, 225:113779, 2021 : PubMed


    Title: Selective Pseudo-irreversible Butyrylcholinesterase Inhibitors Transferring Antioxidant Moieties to the Enzyme Show Pronounced Neuroprotective Efficacy In Vitro and In Vivo in an Alzheimer's Disease Mouse Model
    Scheiner M, Hoffmann M, He F, Poeta E, Chatonnet A, Monti B, Maurice T, Decker M
    Ref: Journal of Medicinal Chemistry, 64(13)::9302, 2021 : PubMed


    Title: Photopharmacology on Acetylcholinesterase: Novel Photoswitchable Inhibitors with Improved Pharmacological Profiles
    Scheiner M, Sink A, Spatz P, Endres E, Decker M
    Ref: ChemPhotoChem, 5:149, 2021 : PubMed


    Title: Sterubin: Enantioresolution and Configurational Stability, Enantiomeric Purity in Nature, and Neuroprotective Activity in Vitro and in Vivo
    Hofmann J, Fayez S, Scheiner M, Hoffmann M, Oerter S, Appelt-Menzel A, Maher P, Maurice T, Bringmann G, Decker M
    Ref: Chemistry, 26:7299, 2020 : PubMed


    Title: Highly Selective Butyrylcholinesterase Inhibitors with Tunable Duration of Action by Chemical Modification of Transferable Carbamate Units Exhibit Pronounced Neuroprotective Effect in an Alzheimer's Disease Mouse Model
    Hoffmann M, Stiller C, Endres E, Scheiner M, Gunesch S, Sotriffer C, Maurice T, Decker M
    Ref: Journal of Medicinal Chemistry, 62:9116, 2019 : PubMed


    Title: Multi-target-directed-ligands acting as enzyme inhibitors and receptor ligands
    Rodriguez-Soacha DA, Scheiner M, Decker M
    Ref: Eur Journal of Medicinal Chemistry, 180:690, 2019 : PubMed


    Title: Dual-Acting Cholinesterase-Human Cannabinoid Receptor 2 Ligands Show Pronounced Neuroprotection in Vitro and Overadditive and Disease-Modifying Neuroprotective Effects in Vivo
    Scheiner M, Dolles D, Gunesch S, Hoffmann M, Nabissi M, Marinelli O, Naldi M, Bartolini M, Petralla S and Decker M <8 more author(s)>
    Ref: Journal of Medicinal Chemistry, 62:9078, 2019 : PubMed


    Title: Aminobenzimidazoles and Structural Isomers as Templates for Dual-Acting Butyrylcholinesterase Inhibitors and hCB2 R Ligands To Combat Neurodegenerative Disorders
    Dolles D, Nimczick M, Scheiner M, Ramler J, Stadtmuller P, Sawatzky E, Drakopoulos A, Sotriffer C, Wittmann HJ and Decker M <1 more author(s)>
    Ref: ChemMedChem, 11:1270, 2016 : PubMed


Send your questions or comments to :
Mail to: Nicolas Lenfant, Thierry Hotelier, Yves Bourne, Pascale Marchot and Arnaud Chatonnet.
Please cite: Lenfant 2013 Nucleic.Acids.Res. or Marchot Chatonnet 2012 Prot.Pept Lett.
For technical information about these pages see:
ESTHER Home Page and ACEDB Home Page
AcePerl Lincoln Stein Home Page

Acknowledgements and disclaimer